Cargando…

Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and the European Thyroid Association

Thyroid eye disease (TED) remains challenging for clinicians to evaluate and manage. Novel therapies have recently emerged, and their specific roles are still being determined. Most patients with TED develop eye manifestations while being treated for hyperthyroidism and under the care of endocrinolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Burch, Henry B., Perros, Petros, Bednarczuk, Tomasz, Cooper, David S., Dolman, Peter J., Leung, Angela M., Mombaerts, Ilse, Salvi, Mario, Stan, Marius N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807259/
https://www.ncbi.nlm.nih.gov/pubmed/36480280
http://dx.doi.org/10.1089/thy.2022.0251
_version_ 1784862683811545088
author Burch, Henry B.
Perros, Petros
Bednarczuk, Tomasz
Cooper, David S.
Dolman, Peter J.
Leung, Angela M.
Mombaerts, Ilse
Salvi, Mario
Stan, Marius N.
author_facet Burch, Henry B.
Perros, Petros
Bednarczuk, Tomasz
Cooper, David S.
Dolman, Peter J.
Leung, Angela M.
Mombaerts, Ilse
Salvi, Mario
Stan, Marius N.
author_sort Burch, Henry B.
collection PubMed
description Thyroid eye disease (TED) remains challenging for clinicians to evaluate and manage. Novel therapies have recently emerged, and their specific roles are still being determined. Most patients with TED develop eye manifestations while being treated for hyperthyroidism and under the care of endocrinologists. Endocrinologists, therefore, have a key role in diagnosis, initial management, and selection of patients who require referral to specialist care. Given that the need for guidance to endocrinologists charged with meeting the needs of patients with TED transcends national borders, and to maximize an international exchange of knowledge and practices, the American Thyroid Association and European Thyroid Association joined forces to produce this consensus statement.
format Online
Article
Text
id pubmed-9807259
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Mary Ann Liebert, Inc., publishers
record_format MEDLINE/PubMed
spelling pubmed-98072592023-01-11 Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and the European Thyroid Association Burch, Henry B. Perros, Petros Bednarczuk, Tomasz Cooper, David S. Dolman, Peter J. Leung, Angela M. Mombaerts, Ilse Salvi, Mario Stan, Marius N. Thyroid Guidelines and Statements Thyroid eye disease (TED) remains challenging for clinicians to evaluate and manage. Novel therapies have recently emerged, and their specific roles are still being determined. Most patients with TED develop eye manifestations while being treated for hyperthyroidism and under the care of endocrinologists. Endocrinologists, therefore, have a key role in diagnosis, initial management, and selection of patients who require referral to specialist care. Given that the need for guidance to endocrinologists charged with meeting the needs of patients with TED transcends national borders, and to maximize an international exchange of knowledge and practices, the American Thyroid Association and European Thyroid Association joined forces to produce this consensus statement. Mary Ann Liebert, Inc., publishers 2022-12-01 2022-12-13 /pmc/articles/PMC9807259/ /pubmed/36480280 http://dx.doi.org/10.1089/thy.2022.0251 Text en © American Thyroid Association and European Thyroid Association. Published by Mary Ann Liebert, Inc. https://creativecommons.org/licenses/by/4.0/This Open Access article is distributed under the terms of the Creative Commons License [CC-BY] (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Guidelines and Statements
Burch, Henry B.
Perros, Petros
Bednarczuk, Tomasz
Cooper, David S.
Dolman, Peter J.
Leung, Angela M.
Mombaerts, Ilse
Salvi, Mario
Stan, Marius N.
Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and the European Thyroid Association
title Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and the European Thyroid Association
title_full Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and the European Thyroid Association
title_fullStr Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and the European Thyroid Association
title_full_unstemmed Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and the European Thyroid Association
title_short Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and the European Thyroid Association
title_sort management of thyroid eye disease: a consensus statement by the american thyroid association and the european thyroid association
topic Guidelines and Statements
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807259/
https://www.ncbi.nlm.nih.gov/pubmed/36480280
http://dx.doi.org/10.1089/thy.2022.0251
work_keys_str_mv AT burchhenryb managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation
AT perrospetros managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation
AT bednarczuktomasz managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation
AT cooperdavids managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation
AT dolmanpeterj managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation
AT leungangelam managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation
AT mombaertsilse managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation
AT salvimario managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation
AT stanmariusn managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation